Matrix Biology Plus

SJR Rank #3,842H-index: 27SJR: 1.161Best quartile: Q1Open AccessAPC: US$2,360Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Elsevier B.V.

Country

Netherlands

Type

journal

SJR by Edition

2022202500.30.60.91.2

Subject Categories

  • BiochemistryQ1
  • BiophysicsQ1
  • HistologyQ1
  • Cell BiologyQ2
  • GeneticsQ2
  • Molecular BiologyQ2

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

Cell Adhesion Molecules ResearchConnective tissue disorders researchProteoglycans and glycosaminoglycans researchProtease and Inhibitor MechanismsCellular Mechanics and InteractionsTendon Structure and TreatmentTissue Engineering and Regenerative MedicineGlycosylation and Glycoproteins ResearchTrauma, Hemostasis, Coagulopathy, ResuscitationBone and Dental Protein Studies

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs015304560

Documents per Year

2022202507142128

Detailed Information

ISSN

2590-0285

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

2.81

References per Document

46.12

Coverage

2019-2026

Scope

Matrix Biology Plus, a companion title to Matrix Biology, is an online-only, open access, peer-reviewed journal. It offers the quality, visibility, and impact of Matrix Biology, combined with the convenience and reach of timely on-line access for the readers in the matrix biology community. Matrix Biology Plus has a broader scope than Matrix Biology, including computational biology, biomaterials, biophysics, and bioengineering research in addition to or in combination with biology and medicine. Matrix Biology Plus welcomes: - Comparative and correlative studies focused on extracellular matrix and cell-matrix interactions - New methodologies for studying extracellular matrix and cell-matrix interac-tions in health and disease - New structural/biochemical and biophysical, biological or bioengineering models and tools (e.g., detailed description of novel transgenic mice, novel disease models, novel biomaterials, novel bioengineering devices and strat-egies focused on the matrix) - New computational tools for matrix modeling and newly established data-bases and repositories focused on the matrix and its components - Omics datasets that are novel, experimentally derived, descriptive, and comprehensive (e.g., proteomics, transcriptomics, genomics, metabolomics, and interactomics datasets). However, simple analysis of published datasets or extraction from public-access databases where no further substantive ex-perimental or computational analysis is undertaken is unlikely to be deemed appropriate. - Genomics/transcriptomic studies - Matrix-targeted therapeutics (chemistry, engineering, fabrica-tion/manufacture, target validation, drug delivery, nanomedicine) and matrix-derived therapeutics - Clinical and population-based studies of matrix components and disease linked mutations

Metrics from SCImago Journal Rank 2025. View on SCImago